8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-25-100264
Regulation FD disclosure · Other events
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading plx-20251017x8k.htm…